We are live on ! Find out more
RAM

Roanoke Asset Management Portfolio holdings

AUM $292M
1-Year Est. Return 6.35%
This Fund
S&P 500
This Quarter Est. Return
-14.32%
1 Year Est. Return
+6.35%
3 Year Est. Return
+50.34%
5 Year Est. Return
+191.13%
10 Year Est. Return
+336.09%
AUM
$223M
AUM Growth
-$46M
Cap. Flow
-$1.8M
Cap. Flow %
-0.81%
Top 10 Hldgs %
34.29%
Holding
115
New
–
Increased
19
Reduced
38
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$802K
2
GSK icon
GSK
GSK
+$235K
3
NEE icon
NextEra Energy
NEE
+$145K
4
CVS icon
CVS Health
CVS
+$125K
5
BAC icon
Bank of America
BAC
+$122K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$830K
2
HD icon
Home Depot
HD
+$698K
3
RCL icon
Royal Caribbean
RCL
+$491K
4
STRS icon
Stratus Properties
STRS
+$255K
5
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$215K

Sector Composition

Rank Sector Weight
1 Technology 28.03%
2 Healthcare 18.56%
3 Financials 16.32%
4 Consumer Discretionary 11.22%
5 Energy 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAC.PRB icon
76
Bank of America Depository Shares Series GG
BAC.PRB
$1.33B
$454K 0.2%
18,000
– –
AEP icon
77
American Electric Power
AEP
$68.8B
$452K 0.2%
4,710
– –
MS.PRO icon
78
Morgan Stanley 4.250% Series O Preferred Stock
MS.PRO
$862M
$451K 0.2%
25,000
– –
GIS icon
79
General Mills
GIS
$19.2B
$446K 0.2%
5,910
– –
DVN icon
80
Devon Energy
DVN
$48.5B
$413K 0.19%
7,500
– –
GS.PRK
81
DELISTED
GOLDMAN SACHS GROUP, INC. THE 6.375%
GS.PRK
$390K 0.18%
15,000
– –
CORT icon
82
Corcept Therapeutics
CORT
$12B
$357K 0.16%
15,000
-5,000
-25% -$109K
ASH icon
83
Ashland
ASH
$3.28B
$354K 0.16%
3,435
-1,500
-30% -$153K
KEY.PRJ icon
84
KeyCorp Series F Preferred Stock
KEY.PRJ
$365M
$353K 0.16%
15,000
– –
INTC icon
85
Intel
INTC
$510B
$343K 0.15%
9,179
– –
SCHW.PRJ icon
86
Charles Schwab 4.450% Series J Preferred Stock
SCHW.PRJ
$416M
$327K 0.15%
16,000
– –
TRGP icon
87
Targa Resources
TRGP
$55.8B
$312K 0.14%
5,222
– –
V icon
88
Visa
V
$688B
$301K 0.14%
1,530
– –
ED icon
89
Consolidated Edison
ED
$40B
$291K 0.13%
3,055
– –
EW icon
90
Edwards Lifesciences
EW
$51.3B
$291K 0.13%
3,060
– –
SPY icon
91
State Street SPDR S&P 500 ETF Trust
SPY
$819B
$290K 0.13%
770
– –
COP icon
92
ConocoPhillips
COP
$140B
$270K 0.12%
3,011
– –
BAC.PRS icon
93
Bank of America Depository Shares Series SS
BAC.PRS
$506M
$269K 0.12%
13,000
– –
VSH icon
94
Vishay Intertechnology
VSH
$5.09B
$243K 0.11%
13,610
-3
-0% -$57
MCO icon
95
Moody's
MCO
$83.8B
$236K 0.11%
866
– –
DXCM icon
96
DexCom
DXCM
$31.2B
$228K 0.1%
3,060
– –
JPM.PRK icon
97
JPMorgan Chase & Co 4.55% Series JJ Preferred Stock
JPM.PRK
$1.08B
$227K 0.1%
11,550
– –
STRS icon
98
Stratus Properties
STRS
$159M
$226K 0.1%
7,000
-6,500
-48% -$255K
JPM.PRD icon
99
JPMorgan Chase & Co 5.75% Series DD Preferred Stock
JPM.PRD
$1.61B
$224K 0.1%
9,000
– –
D icon
100
Dominion Energy
D
$60B
$220K 0.1%
2,762
– –
1 2 3
4
5

Similar funds

WFA
Wade Financial Advisory Campbell, California $292M AUM 5.04% 1-Year Est. Return
HCA
Horan Capital Advisors Cincinnati, Ohio $297M AUM 9.75% 1-Year Est. Return
WGCA
Wolf Group Capital Advisors Fairfax, Virginia $298M AUM 8.97% 1-Year Est. Return
RI
Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return
BCM
BluePointe Capital Management Menlo Park, California $262M AUM 9.24% 1-Year Est. Return
PPWP
Proquility Private Wealth Partners Las Vegas, Nevada $324M AUM 8.88% 1-Year Est. Return
IAM
Impact Asset Management Vienna $255M AUM
UFA
US Financial Advisors Braintree, Massachusetts $338M AUM 4.11% 1-Year Est. Return

Roanoke Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Roanoke Asset Management held 115 positions worth $223M, down 17% from $269M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 3.5%. Roanoke Asset Management opened no new positions and exited 4, leaving the 115-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

  • Roanoke Asset Management added most to Bristol-Myers Squibb in Q2 2022, an estimated $802K increase.
  • Roanoke Asset Management's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $830K.
  • Roanoke Asset Management fully exited iShares Russell 2000 Growth ETF in Q2 2022, selling an estimated $215K.
  • Roanoke Asset Management's ten largest holdings make up 34% of its $223M portfolio in Q2 2022.
  • Roanoke Asset Management opened 0 new positions and closed 4 in Q2 2022.
  • Roanoke Asset Management's portfolio value fell 17% quarter-over-quarter to $223M.

Based on Roanoke Asset Management's 13F filing for Q2 2022, filed 10 Aug 2022.